Related Experiment Video

Updated: Jun 19, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Prevention of type 2 diabetes: risk status, clinic, and community

K M Venkat Narayan1, David F Williamson

  • 1Hubert Department of Global Health, The Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta, GA 30322, USA. knaraya@emory.edu

Journal of General Internal Medicine
|November 6, 2009
PubMed

Insights

Preventing type 2 diabetes is possible through lifestyle interventions, which are more effective than metformin. Focusing prevention efforts on high-risk individuals, particularly those with pre-diabetes, is crucial for cost-effectiveness.

Area of Science:

  • Endocrinology
  • Preventive Medicine
  • Public Health

Background:

  • Type 2 diabetes prevention strategies have been explored since insulin's discovery.
  • Recent clinical trials confirm that diabetes can be effectively prevented or delayed.

Purpose of the Study:

  • To evaluate the efficacy of lifestyle interventions and metformin in preventing type 2 diabetes.
  • To assess the cost-effectiveness of diabetes prevention programs.
  • To identify optimal strategies for resource allocation in diabetes prevention.

Main Methods:

  • Analysis of clinical trial data on lifestyle intervention and metformin efficacy.
  • Examination of prevention trial evidence from individuals with pre-diabetes and normoglycemic status.
  • Assessment of cost-effectiveness in community-based prevention programs with unknown glycemic status.

Main Results:

  • Lifestyle intervention demonstrated over 50% reduction in diabetes incidence, outperforming metformin.
  • Interventions showed minimal impact on diabetes incidence in normoglycemic individuals.
  • Prevention programs including normoglycemic participants reduce overall cost-effectiveness.

Conclusions:

  • Lifestyle intervention is a highly effective strategy for preventing type 2 diabetes, especially in individuals with pre-diabetes.
  • Targeting high-risk populations is essential for economically sustainable diabetes prevention.
  • Collaboration between clinical settings, community programs, and payers is necessary to optimize resource allocation for diabetes prevention.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...